SG Americas Securities’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Buy |
|
|||||
|
2025
Q2 | $7.71M | Buy |
|
|||||
|
2025
Q1 | $5.19M | Sell |
|
|||||
|
2024
Q4 | $9.23M | Sell |
|
|||||
|
2024
Q3 | $11.3M | Sell |
|
|||||
|
2024
Q2 | $10.6M | Buy |
|
|||||
|
2024
Q1 | $8.61M | Buy |
|
|||||
|
2023
Q4 | $5.69M | Buy |
|
|||||
|
2023
Q3 | $4.22M | Buy |
|
|||||
|
2023
Q2 | $1.51M | Buy |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $1.45M | Buy |
|
|||||
|
2022
Q3 | $1.15M | Sell |
|
|||||
|
2022
Q2 | $3.98M | Sell |
|
|||||
|
2022
Q1 | $5.21M | Sell |
|
|||||
|
2021
Q4 | $6.7M | Sell |
|
|||||
|
2021
Q3 | $8.55M | Sell |
|
|||||
|
2021
Q2 | $12.6M | Sell |
|
|||||
|
2021
Q1 | $16.7M | Buy |
|
|||||
|
2020
Q4 | $11.6M | Buy |
|
|||||
|
2020
Q3 | $8.58M | Buy |
|
|||||
|
2020
Q2 | $4.78M | Buy |
|
|||||
|
2020
Q1 | $2.3M | Sell |
|
|||||
|
2019
Q4 | $9.6M | Buy |
|
|||||
|
2019
Q3 | $2.54M | Sell |
|
|||||
|
2019
Q2 | $4.3M | Buy |
|
|||||
|
2019
Q1 | $1.75M | Sell |
|
|||||
|
2018
Q4 | $9.83M | Buy |
|
|||||
|
2018
Q3 | $2.58M | Sell |
|
|||||
|
2018
Q2 | $6.35M | Buy |
|
|||||
|
2018
Q1 | $1.93M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $10.5M | Buy |
|
|||||
|
2017
Q2 | $17.1M | Buy |
|
|||||
|
2017
Q1 | $13.7M | Buy |
|
|||||
|
2016
Q4 | $10.3M | Buy |
|
|||||
|
2016
Q3 | $7.04M | Sell |
|
|||||
|
2016
Q2 | $14.8M | Buy |
|
|||||
|
2016
Q1 | $4M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $3.87M | Buy |
|
|||||
|
2015
Q2 | $3.36M | Buy |
|
|||||
|
2015
Q1 | $2.61M | Sell |
|
|||||
|
2014
Q4 | $4.81M | Sell |
|
|||||
|
2014
Q3 | $50.9M | Sell |
|
|||||
|
2014
Q2 | $53.7M | Buy |
|
|||||
|
2014
Q1 | $5.24M | Sell |
|
|||||
|
2013
Q4 | $4.61M | Sell |
|
|||||
|
2013
Q3 | $5.05M | Buy |
|
|||||
|
2013
Q2 | $4.71M | Buy |
|